Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
This article compares retirement index funds and target date funds to help you decide which aligns with your goals and timeline.
26,044 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
OpenAI teams with Broadcom to introduce its first custom AI accelerator, Jalapeño. The move signals a broader strateg...
Citigroup unveils a defensive blueprint to weather AI-led market swings, leaning on bonds and smaller-company stocks....
A timely macro rebuttal from Citadel Securities challenges a viral AI-doomsday scenario, arguing that current data sh...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
Home Depot and Lowe's are racing to harness AI to sharpen pricing, streamline operations, and boost customer experien...
Headline rent figures hide true costs faced by tenants. This piece explains why the 'average rent' mirage misleads, a...
When the national debt climbs past the size of the economy, it can ripple through interest rates and monthly payments...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
With housing payments rising and rates lingering near multi-year highs, five categories of monthly dividend investmen...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...